Innova Captab

779.55
+3.90
(0.50%)
Market Cap
4,460.97 Cr
EPS
18.66
PE Ratio
34.85
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
1,260.00
52 Week low
421.35
PB Ratio
4.96
Debt to Equity
0.38
Add Ratio

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from2 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy100.00 %
100.00 %
Hold0.0 %
0.0 %
Sell0.0 %
0.0 %
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,683.45 4,03,916.05 34.10 49,887.20 12.06 9,648 13.77 52.67
5,620.45 1,49,205.29 72.77 8,184.00 0.89 1,600 64.53 45.57
1,461.90 1,18,065.10 23.53 26,520.70 14.17 4,155 47.38 52.92
3,056.05 1,03,430.62 56.27 10,785.70 11.59 1,656 13.54 47.23
1,107.95 92,448.55 17.17 28,905.40 12.36 5,578 1.69 30.37
2,201.15 90,812.16 43.84 10,615.60 19.57 1,942 -16.38 35.15
1,968.45 89,800.21 31.28 20,141.50 19.94 1,936 38.82 43.62
883.10 88,860.52 19.73 19,831.50 13.82 3,831 29.92 40.81
1,094.75 63,583.26 18.24 29,559.20 17.55 3,169 -10.04 43.94
29,597.00 62,891.56 47.49 6,097.20 10.80 1,201 16.01 49.75
Growth Rate
Revenue Growth
16.91 %
Net Income Growth
38.68 %
Cash Flow Change
118.03 %
ROE
-53.82 %
ROCE
-45.34 %
EBITDA Margin (Avg.)
16.22 %

Quarterly Financial Results

Quarterly Financials
Mar 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Revenue
217
244
245
244
234
286
305
268
296
320
321
Expenses
197
211
208
214
202
243
258
225
252
269
270
EBITDA
21
33
37
29
32
44
47
44
44
52
51
Operating Profit %
9 %
13 %
14 %
11 %
13 %
14 %
15 %
15 %
14 %
16 %
15 %
Depreciation
3
3
3
3
3
5
5
3
5
5
5
Interest
3
5
6
5
5
9
7
1
0
0
0
Profit Before Tax
15
25
28
21
25
30
35
40
39
47
46
Tax
2
6
9
4
7
7
10
11
10
12
11
Net Profit
13
19
20
17
18
23
25
29
30
35
34
EPS in ₹
108.91
3.91
4.08
3.59
3.67
4.77
4.39
5.02
5.15
6.12
5.97

Balance Sheet

Balance Sheet
2019
2020
2021
2022
2023
2024
Total Assets
223
245
370
576
704
1,321
Fixed Assets
79
73
79
183
183
358
Current Assets
143
171
271
379
443
580
Capital Work in Progress
0
0
7
0
22
341
Investments
0
0
0
0
0
0
Other Assets
145
172
283
392
500
622
Total Liabilities
223
245
370
576
704
1,321
Current Liabilities
112
120
215
295
278
266
Non Current Liabilities
28
14
10
72
150
225
Total Equity
83
110
145
209
277
831
Reserve & Surplus
71
98
133
197
229
774
Share Capital
12
12
12
12
48
57

Cash Flow

Cash Flow
2019
2020
2021
2022
2023
2024
Net Cash Flow
1
2
3
-5
3
8
Investing Activities
-9
-6
-20
-188
-91
-499
Operating Activities
19
31
42
59
67
146
Financing Activities
-9
-23
-19
125
27
361

Share Holding

% Holding
Jun 2022
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
69.75 %
50.90 %
50.90 %
50.90 %
50.90 %
50.90 %
50.90 %
FIIs
0.00 %
0.00 %
0.00 %
1.94 %
1.19 %
1.01 %
0.74 %
DIIs
0.00 %
11.73 %
4.98 %
20.77 %
21.23 %
20.61 %
19.96 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
32.10 %
32.29 %
25.47 %
25.80 %
26.00 %
26.96 %
Others
30.25 %
5.26 %
11.83 %
0.91 %
0.88 %
1.48 %
1.45 %
No of Share Holders
7
1,39,154
1,39,154
39,396
35,115
32,254
36,692

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Corporate Action

Announcements

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Mar 01, 2025, 15:10
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Feb 26, 2025, 17:04
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Feb 26, 2025, 17:04
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.
Feb 14, 2025, 16:07
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Feb 13, 2025, 18:54
Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Feb 11, 2025, 18:42
Announcement under Regulation 30 (LODR)-Newspaper Publication
Feb 06, 2025, 16:43
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Feb 06, 2025, 16:39
Integrated Filing (Financial)
Feb 05, 2025, 20:22
Statement For Deviation(S) Or Variation(S) Pursuant To Regulation 32 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 For The Quarter En
Feb 05, 2025, 20:13
Announcement under Regulation 30 (LODR)-Investor Presentation
Feb 05, 2025, 19:36
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Feb 05, 2025, 19:28
Approval Of The Un-Audited (Standalone And Consolidated) Financial Results For The Quarter And Nine Months Ended December 31 2024
Feb 05, 2025, 17:28
Integrated Filing (Financial)
Feb 05, 2025, 17:22
Board Meeting Outcome for Outcome Of The Board Meeting Held Today I.E. February 05 2025
Feb 05, 2025, 17:01
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Jan 30, 2025, 15:40
Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 For Consideration Of Un-Audited Financial Re
Jan 29, 2025, 20:45
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Sale Of Property Of Sharon Bio-Medicine Limited Material Subsidiary Of The Company.
Jan 20, 2025, 20:15
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 -Shifting Of Registered Office Of Sharon Bio-Medicine Limited Material Subsidiary Of The Compa
Jan 20, 2025, 20:05
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Jan 14, 2025, 18:11
Disclosure under Regulation 30A of LODR
Jan 14, 2025, 18:03
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Jan 06, 2025, 15:39
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Dec 02, 2024, 17:39
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Nov 23, 2024, 20:20
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Nov 14, 2024, 17:32
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Nov 12, 2024, 18:36
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Nov 12, 2024, 18:20
Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Nov 11, 2024, 17:26
Announcement under Regulation 30 (LODR)-Newspaper Publication
Nov 08, 2024, 17:35
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Nov 08, 2024, 17:29
Statement For Deviation(S) Or Variation(S) Pursuant To Regulation 32 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Quarter And Half Year Ended September 30, 2024
Nov 07, 2024, 21:43
Announcement under Regulation 30 (LODR)-Investor Presentation
Nov 07, 2024, 19:56
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Nov 07, 2024, 18:48
Approval Of The Un-Audited (Standalone And Consolidated) Financial Results For The Quarter And Half Year Ended September 30, 2024.
Nov 07, 2024, 16:59
Board Meeting Outcome for Outcome Of The Board Meeting Held Today I.E. November 07, 2024.
Nov 07, 2024, 16:48
Pursuant To The Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, ('Listing Regulations'), We Wish To Inform You That Our Upcoming Jammu Facility Received 'Drug Manufacturing License' Vide Letter No. CLJK202406146 Dated November 06, 2024 From Government Of Jammu And Kashmir, Department Of Health And Medical Education, Drug Control Organisation, Jammu.
Nov 06, 2024, 19:49
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Oct 29, 2024, 18:05
Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For Consideration Of Un-Audited Financial Results For The Quarter And Half Year Ended September 30, 2024.
Oct 29, 2024, 17:47
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Oct 05, 2024, 15:02
Closure of Trading Window
Sep 26, 2024, 12:14
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Sep 19, 2024, 19:04
Shareholder Meeting / Postal Ballot-Outcome of AGM
Sep 18, 2024, 18:27
Announcement under Regulation 30 (LODR)-Credit Rating
Aug 29, 2024, 19:48
Announcement under Regulation 30 (LODR)-Newspaper Publication
Aug 25, 2024, 20:54
Business Responsibility and Sustainability Reporting (BRSR)
Aug 24, 2024, 18:31
Reg. 34 (1) Annual Report.
Aug 24, 2024, 16:23
Reg. 34 (1) Annual Report.
Aug 23, 2024, 14:27
Intimation Of Notice Of 20Th Annual General Meeting Of The Innova Captab Limited For The Financial Year 2023-24.
Aug 23, 2024, 12:55
Announcement under Regulation 30 (LODR)-Newspaper Publication
Aug 23, 2024, 11:50
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Aug 17, 2024, 14:59

Technical Indicators

RSI(14)
Neutral
42.59
ATR(14)
Less Volatile
52.81
STOCH(9,6)
Neutral
67.32
STOCH RSI(14)
Overbought
93.55
MACD(12,26)
Bullish
12.46
ADX(14)
Strong Trend
32.65
UO(9)
Bearish
48.85
ROC(12)
Downtrend But Slowing Down
-1.08
WillR(14)
Neutral
-34.10